Utah Medical Products, Inc.
UTMD
$56.35
$0.681.22%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -23.83% | -19.68% | -20.87% | -16.60% | -9.74% |
| Total Depreciation and Amortization | -5.64% | -29.80% | -45.45% | -55.31% | -55.42% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 126.70% | 89.91% | 83.10% | 82.41% | -758.46% |
| Change in Net Operating Assets | 5.24% | -90.52% | -361.99% | -673.82% | 51.16% |
| Cash from Operations | -17.85% | -23.58% | -32.09% | -33.44% | -23.88% |
| Capital Expenditure | 12.86% | 18.38% | 36.57% | 64.01% | 47.02% |
| Sale of Property, Plant, and Equipment | -100.00% | -100.00% | -100.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | 100.00% | -- | -- | -- |
| Cash from Investing | 6.23% | 13.73% | 32.83% | 67.45% | 50.77% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -100.00% | 53.13% | 233.33% | 57.26% |
| Repurchase of Common Stock | -6.12% | -84.00% | -575.55% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 5.80% | 4.73% | 2.63% | 0.51% | -0.73% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -5.55% | -61.09% | -239.39% | -472.34% | -327.55% |
| Foreign Exchange rate Adjustments | -89.74% | 345.13% | 78.57% | -299.71% | -30.15% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,822.22% | -253.04% | -181.29% | -155.52% | -98.70% |